Next, according to the OS curve, we found that the high expression of STK4 has a significant (p < 0.001) association with renal cancer (including ccRCC) patients’ survival, which further suggests that STK4 is a reliable prognostic predictor. Here, STK4 is linked to nonpapillary renal cell carcinoma.